Speaking to reporters after launching the Rs 60-lakh project, shared equally by the two institutions, JIPMER Director T S Ravikumar said the project was aimed at combating chronic respiratory diseases which are the second leading cause of death in India, through education, research, patient care and public health innovations.
He said contributions from various agencies and organisations would also be sought to strengthen the project, and to expand it to broader areas where the intensity of the problem of lung disease and lung cancer had been noticed.
The project will be implemented by going into causative factors for lung diseases,including air pollution and smoking.
Dr Karp referred to the serious impact smoking caused among vulnerable sections. She appreciated the collaboration with JIPMER to study various aspects of pulmonary diseases.
Dr Biswal said a two-day Indo-US conference on COPD (Chronic Obstructive Pulmonary Disease) would be held in Pune on Feb 1 and 2, in which a large number of experts and clinicians would participate.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
